Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development

Overview of attention for article published in Annals of Neurology, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 7 news outlets
blogs: 1 blog

twitter: 16 X users

Readers on

mendeley: 72 Mendeley

So far, Altmetric has seen 7 news stories from 7 outlets.

Pridopidine’s Impact on ALS, Assessing Results From HEALEY ALS Platform Trial: Melanie Leitner, PhD

Neurology Live, 23 May 2023

WATCH TIME: 5 minutes "The HEALEY platform trial offers an exciting opportunity to test multiple compounds simultaneously…

Adaptive HEALEY ALS Platform Trial hopes to bring new treatments to patients faster

Science Daily, 28 Feb 2022

A new article describes the approach, structure, and launch of the HEALEY ALS Platform Trial- the first platform trial for…

Adaptive platform trial hopes to bring new treatments to patients faster

Today UK News, 28 Feb 2022

An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent…

Adaptive platform trial hopes to bring new treatments to patients faster

MedicalXpress, 28 Feb 2022

An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.